Related references
Note: Only part of the references are listed.L-Homoarginine and cardiovascular disease
Dorothee Atzler et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2015)
Homoarginine and Cardiovascular Outcome in the Population-Based Dallas Heart Study
Dorothee Atzler et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Do Homoarginine and Asymmetric Dimethylarginine Act Antagonistically in the Cardiovascular System?
Dimitrios Tsikas et al.
CIRCULATION JOURNAL (2014)
Homoarginine and mortality in an older population: the Hoorn study
Stefan Pilz et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2014)
Homoarginine and 3-nitrotyrosine in patients with takotsubo cardiomyopathy
Arslan Arinc Kayacelebi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
L-Homoarginine and L-arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study
Leonard P. van der Zwan et al.
JOURNAL OF HYPERTENSION (2013)
Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients
S. Pilz et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Homoarginine and Progression of Chronic Kidney Disease: Results from the Mild to Moderate Kidney Disease Study
Christiane Drechsler et al.
PLOS ONE (2013)
Homoarginine deficiency is associated with increased bone turnover
S. Pilz et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Symmetrical and Asymmetrical Dimethylarginine as Predictors for Mortality in Patients Referred for Coronary Angiography: The Ludwigshafen Risk and Cardiovascular Health Study
Andreas Meinitzer et al.
CLINICAL CHEMISTRY (2011)
Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients
Christiane Drechsler et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Low homoarginine concentration is a novel risk factor for heart disease
Stefan Pilz et al.
HEART (2011)
Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease
Takhar Kasumov et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Low Serum Homoarginine Is a Novel Risk Factor for Fatal Strokes in Patients Undergoing Coronary Angiography
Stefan Pilz et al.
STROKE (2011)
Homoarginine, Cardiovascular Risk, and Mortality
Winfried Maerz et al.
CIRCULATION (2010)
Genetic loci influencing kidney function and chronic kidney disease
John C. Chambers et al.
NATURE GENETICS (2010)
Relationship between cerebral arterial pulsatility and carotid intima media thickness in diabetic and non-diabetic patients with non-alcoholic fatty liver disease
F. Karakurt et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2009)
Coordinated Regulation of Dimethylarginine Dimethylaminohydrolase-1 and Cationic Amino Acid Transporter-1 by Farnesoid X Receptor in Mouse Liver and Kidney and Its Implication in the Control of Blood Levels of Asymmetric Dimethylarginine
Jiang Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Multiple loci associated with indices of renal function and chronic kidney disease
Anna Koettgen et al.
NATURE GENETICS (2009)
The L-arginine/NO pathway in end-stage liver disease and during orthotopic liver and kidney transplantation: Biological and analytical ramifications
Thomas Becker et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2009)
Serum L-Homoarginine Concentration is Elevated During Normal Pregnancy and is Related to Flow-Mediated Vasodilatation
Pirjo Valtonen et al.
CIRCULATION JOURNAL (2008)
The Prominent Role of the Liver in the Elimination of Asymmetric Dimethylarginine (ADMA) and the Consequences of Impaired Hepatic Function
Milan C. Richir et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2008)
Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method
Andreas Meinitzer et al.
CLINICA CHIMICA ACTA (2007)
Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: Evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease
Dimitrios Tsikas et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure
Rajeshwar P. Mookerjee et al.
LIVER TRANSPLANTATION (2007)
ADMA correlates with portal pressure in patients with compensated cirrhosis
F. Vizzutti et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis
Rajeshwar P. Mookerjee et al.
HEPATOLOGY (2007)
Symmetrical dimethylarginine:: A new combined parameter for renal function and extent of coronary artery disease
Stefanie M. Bode-Boeger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis
W Laleman et al.
HEPATOLOGY (2005)
The human liver clears both asymmetric and symmetric dimethylarginine
MPC Siroen et al.
HEPATOLOGY (2005)
The transplanted liver graft is capable of clearing asymmetric dimethylarginine
MPC Siroen et al.
LIVER TRANSPLANTATION (2004)
Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis
P Lluch et al.
JOURNAL OF HEPATOLOGY (2004)
Elevation of asymmetric dimethylarginine (ADMA) in patients developing hepatic failure after major hepatectomy
RJ Nijveldt et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2004)
The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA)
RJ Nijveldt et al.
CLINICAL NUTRITION (2003)
Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality
RJ Nijveldt et al.
CLINICAL NUTRITION (2003)
Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography
T Teerlink et al.
ANALYTICAL BIOCHEMISTRY (2002)
Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox
D Tsikas et al.
FEBS LETTERS (2000)
Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography-mass spectrometry
D Tsikas et al.
JOURNAL OF CHROMATOGRAPHY B (2000)
Share Paper
